semaglutide ckd trial Semaglutides Are Poised to Remake Chronic Kidney Disease Care Kidney and Survival Benefits of
Description
Empowering healthcare through accessibility and innovation
GLP-1 RAs provide sustained central and peripheral GLP-1R activation that blunts appetite via hypothalamusvagusNTS circuits, improves metabolic health, and may reduce alcohol and other substance-related craving and reward signals.
Semaglutide is a type of GLP-1 medication thats taken as a weekly injection
Personally tested and nurse practitioner approved.
A woman with lupus shares her experience with being prescribed semaglutide for weight loss, and the pros and cons of this new medication.
The FDA approves Wegovy, the first oral GLP-1 pill, offering a new weight loss solution for those struggling with obesity and overweight.
